An Introduction to COVID-19
On 11 March 2020, the World Health Organization declared COVID-19 a global pandemic. The impact on the medical community has been huge, not only on the front line of medical care but also for those navigating patient treatment during this unprecedented situation.
The touchONCOLOGY expert faculty have been sharing their experiences and advice during this challenging time through video interviews and short articles.
Pamela Kearns: Leading SIOP Europe during the COVID-19 Pandemic
touchONCOLOGY spoke to Professor Pamela Kearns (University of Birmingham, UK) to discuss her experience as President of SIOP Europe during the COVID-19 pandemic, and the biggest achievements of the European paediatric oncology community during that time. Questions How would you describe your experience as the SIOP Europe President (2019–21) and how the COVID-19 pandemic influenced […]
COVID Coagulopathy and Thrombosis: A Systematic Review
touchREVIEWS in Oncology & Haematology. 2022;18(1):78–87 DOI: https://doi.org/10.17925/OHR.2022.18.1.78
In December 2019, an outbreak of pneumonia of unknown aetiology was observed in the Chinese city of Wuhan, capital of Hubei province. By January 2020, this outbreak was attributed to a novel virus classified as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the latest member of the coronaviridae family responsible for major infectious outbreaks, including […]
Morgan Rouprêt, ESOU22: What Have We Learned From the COVID-19 Pandemic?
touchONCOLOGY are joined by the EAU Section of Oncological Urology (ESOU) Chairman Professor Morgan Rouprêt to discuss what we have learned from the COVID-19 pandemic, how this has impacted the care of cancer patients and what we can do to move forward. Questions What was the impact of the COVID-19 pandemic on […]
Mark Lawler, European Cancer Summit 2021: Time To Act: COVID-19 & Cancer Campaign
We were delighted to catch up with Prof Mark Lawler to discuss the challenges that the COVID-19 pandemic has had on cancer care in Europe, and the key objectives and messages of the Time To Act: COVID-19 & Cancer campaign. Questions 1. What has been the impact of the COVID-19 pandemic on cancer screening and […]
Scott Shepherd, ESMO 2021: The CAPTURE Study: Adaptive Immunity to SARS-CoV-2 Infection and Vaccination in Cancer Patients (Part Two)
touchONCOLOGY joins Dr Scott Shepherd (London, UK), to discuss his presentation at ESMO 2021 on the CAPTURE study exploring adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients. To view Part One click here. Questions 1. How did immune responses relate to cancer stage and disease status? (00:18-03:26) 2. What are the implications of […]
Scott Shepherd, ESMO 2021: The CAPTURE Study: Adaptive Immunity to SARS-CoV-2 Infection and Vaccination in Cancer Patients (Part One)
touchONCOLOGY joins Dr Scott Shepherd (London, UK), to discuss his presentation at ESMO 2021 on the CAPTURE study exploring adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients. To view Part Two click here. Questions 1. What were the aims and design of the CAPTURE study? (00:18-02:25) 2. What were the study findings in […]
Markus Joerger, ESMO 2021: Final Results of SAKK 80/20 – COVID-19 Infection in Cancer Patients
touchONCOLOGY joins Dr Markus Joerger (St. Gallen Cancer Center, Switzerland) at ESMO 2021 to discuss the outcome and prognostic factors of COVID-19 infection in cancer patients. Questions 1. What were the objectives of the SAKK 80/20 study? (00:15-00:50) 2. Could you give us a brief overview of the patient population of this study? (00:50-02:14) 3. […]
COVID-19 Vaccination in Patients with Chronic Lymphocytic Leukaemia: What Can We Expect?
touchREVIEWS in Oncology & Haematology. 2021;17(1):7-8 DOI: https://doi.org/10.17925/OHR.2021.17.1.7
Advanced age and other comorbid conditions put patients with chronic lymphocytic leukaemia (CLL) at an increased risk of morbidity and mortality from SARS-CoV-2 infection, with early studies showing case fatality rates of over 30% in patients with CLL with symptomatic COVID-19.1,2 As the vaccination against COVID-19 is becoming available for use in the general population, its […]
Mark Lawler, European Cancer Summit 2020 – Impact of COVID-19 on Cancer
The COVID-19 pandemic has had a huge impact on us all, but particularly patients with cancer. Prof. Mark Lawler tells touchONCOLOGY about the data he presented at this year’s European Cancer Summit, the challenges patients with cancer face as a result of the pandemic, and steps taken to help mitigate this effect. Questions You presented […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!